Story · Medicine & Biotech · Health Tech

At ASH, drugmakers to showcase early data for three-pronged cancer therapies

1 outlet · first reported by BioPharma Dive 6d ago

Coverage, in order

  1. 6d ago
    BioPharma Dive indie
    At ASH, drugmakers to showcase early data for three-pronged cancer therapies

    J&J and AbbVie are among the companies advancing “trispecific” antibodies that could become another step forward in treatment for multiple myeloma.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.